Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-02-23

Clinical Trial Update: Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the combination of Lucentis (ranibizumab) therapy with micropulse diode laser for diabetic macular edema. The current trial stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lucentis (ranibizumab)

Snippet

Sponsor: GWT-TUD GmbH | Conditions: Diabetic Macular Edema | Phase 4 | Status: UNKNOWN